1993 17 Yorke ED, Jackson A, Rosenzweig KE, Braban L, Leibel SA

1993. 17. Yorke ED, Jackson A, Rosenzweig KE, Braban L, Leibel SA, Ling CC: Correlation

of dosimetric factors and radiation pneumonitis for non-small-cell lung AZD1390 cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 2005, 63:672–682.PubMedCrossRef 18. Graham MV, Purdy JA, Emami B, Harms W, Bosch W, Lockett MA, Perez CA: Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999, 45:323–329.PubMed 19. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal Official Statement of the European Respiratory Society. Eur BLZ945 research buy Respir J 1993,6(Suppl 16):5–40. 20. Prediletto R, Paoletti P, Fornai E, Perissinotto A, Petruzzelli S, PARP phosphorylation Formichi B, Ruschi

S, Palla A, Giannella-Neto A, Giuntini C: Natural course of treated pulmonary embolism Evaluation by perfusion lung scintigraphy, gas exchange, and chest roentgenogram. Chest 1990,97(3):554–61.PubMedCrossRef 21. COMMON TOXICITY CRITERIA (CTC) [http://​ctep.​cancer.​gov/​protocolDevelopm​ent/​electronic_​applications/​docs/​ctcv20_​4-30-992.​pdf] 22. LENT SOMA: Tables Radiother Oncol. 1995, 35:17–60.CrossRef 23. Common Terminology Criteria for Adverse Events (CTCAE): Version 4.02. [http://​evs.​nci.​nih.​gov/​ftp1/​CTCAE/​CTCAE_​4.​02_​2009-09-15_​QuickReference_​8.​5x11.​pdf] 24. Nishioka A, Ogawa Y, Hamada N, Terashima M, Inomata T, Yoshida S: Analysis of radiation pneumonitis and radiation-induced lung fibrosis in breast cancer patients after breast conservation treatment. Oncol Rep 1999, 6:513–517.PubMed 25. Wennberg B, Gagliardi G, Sundbom L, Svane G, Lind P: Early response of lung in breast cancer irradiation: radiologic density changes measured by ct and symptomatic radiation pneumonitis. Int J Radiat Oncol Biol Phys 2002, 52:1196–1206.PubMedCrossRef aminophylline 26. Fisher J, Scott C, Stevens R, Marconi B, Champion

L, Freedman GM, Asrari F, Pilepich MV, Gagnon JD, Wong G: Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97–13. Int J Radiat Oncol Biol Phys 2000,48(5):1307–10.PubMedCrossRef 27. Lind PA, Rosfors S, Wennberg B, Glas U, Bevegård S, Fornander T: Pulmonary function following adjuvant chemotherapy and radiotherapy for breast cancer and the issue of three-dimensional treatment planning. Radiother Oncol 1998, 49:245–54.PubMedCrossRef 28. Dörr W, Bertmann S, Herrmann T: Radiation induced lung reactions in breast cancer therapy. Modulating factors and consequential effects. Strahlenther Onkol 2005,181(9):567–73.PubMedCrossRef 29.

Comments are closed.